US Patent 7101894 Bicyclic compounds as inhibitors of chemokine binding to US28

Patent 7101894 was granted and assigned to ChemoCentryx on September, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

ChemoCentryx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7101894

Patent Inventor Names

Thomas J. Schall0

Daniel J. Dairaghi0

J. J. Wright0

Mark Penfold0

Brian E. McMaster0

Date of Patent

September 5, 2006

Patent Application Number

10233326

Date Filed

August 29, 2002

Patent Primary Examiner

‌

Shengjun Wang

Patent abstract

Methods for treating CMV or a CMV-related disease are provided that use compounds having the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7101894 Bicyclic compounds as inhibitors of chemokine binding to US28

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API